These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12388551)

  • 41. Classical pathway complement activation in Kawasaki syndrome.
    Kohsaka T; Abe J; Asahina T; Kobayashi N
    J Allergy Clin Immunol; 1994 Feb; 93(2):520-5. PubMed ID: 8120278
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activation of the alternative pathway of complement in psoriatic lesional skin.
    Takematsu H; Tagami H
    Dermatologica; 1990; 181(4):289-92. PubMed ID: 2073958
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mouse complement component C4 is devoid of classical pathway C5 convertase subunit activity.
    Ebanks RO; Isenman DE
    Mol Immunol; 1996 Feb; 33(3):297-309. PubMed ID: 8649451
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The synthesis of a water soluble complement activating polyacrylic acid-IgG polymer.
    Schmer G; Henderson RA; Müller W
    J Biomater Sci Polym Ed; 1994; 6(1):67-78. PubMed ID: 7947474
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic alterations of the BRI2 gene: familial British and Danish dementias.
    Ghiso J; Rostagno A; Tomidokoro Y; Lashley T; Bojsen-Møller M; Braendgaard H; Plant G; Holton J; Lal R; Revesz T; Frangione B
    Brain Pathol; 2006 Jan; 16(1):71-9. PubMed ID: 16612984
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Familial British dementia: colocalization of furin and ABri amyloid.
    Schwab C; Hosokawa M; Akiyama H; McGeer PL
    Acta Neuropathol; 2003 Sep; 106(3):278-84. PubMed ID: 12883829
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.
    Manzi S; Rairie JE; Carpenter AB; Kelly RH; Jagarlapudi SP; Sereika SM; Medsger TA; Ramsey-Goldman R
    Arthritis Rheum; 1996 Jul; 39(7):1178-88. PubMed ID: 8670328
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Complement activation by 3-mercapto-1,2-propanediol immobilized on gold surfaces.
    Tengvall P; Askendal A; Lundström I
    Biomaterials; 1996 May; 17(10):1001-7. PubMed ID: 8736735
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A stop-codon mutation in the BRI gene associated with familial British dementia.
    Vidal R; Frangione B; Rostagno A; Mead S; Révész T; Plant G; Ghiso J
    Nature; 1999 Jun; 399(6738):776-81. PubMed ID: 10391242
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Complement activation by neurofibrillary tangles in Alzheimer's disease.
    Shen Y; Lue L; Yang L; Roher A; Kuo Y; Strohmeyer R; Goux WJ; Lee V; Johnson GV; Webster SD; Cooper NR; Bradt B; Rogers J
    Neurosci Lett; 2001 Jun; 305(3):165-8. PubMed ID: 11403931
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aspartate residue 7 in amyloid beta-protein is critical for classical complement pathway activation: implications for Alzheimer's disease pathogenesis.
    Velazquez P; Cribbs DH; Poulos TL; Tenner AJ
    Nat Med; 1997 Jan; 3(1):77-9. PubMed ID: 8986745
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Complement-dependent proinflammatory properties of the Alzheimer's disease beta-peptide.
    Bradt BM; Kolb WP; Cooper NR
    J Exp Med; 1998 Aug; 188(3):431-8. PubMed ID: 9687521
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Generation and initial characterization of FDD knock in mice.
    Giliberto L; Matsuda S; Vidal R; D'Adamio L
    PLoS One; 2009 Nov; 4(11):e7900. PubMed ID: 19924302
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of complement system components during aging and amyloid deposition in APP transgenic mice.
    Reichwald J; Danner S; Wiederhold KH; Staufenbiel M
    J Neuroinflammation; 2009 Nov; 6():35. PubMed ID: 19917141
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Covalent association of C3b with C4b within C5 convertase of the classical complement pathway.
    Takata Y; Kinoshita T; Kozono H; Takeda J; Tanaka E; Hong K; Inoue K
    J Exp Med; 1987 Jun; 165(6):1494-507. PubMed ID: 3495629
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Furin mediates enhanced production of fibrillogenic ABri peptides in familial British dementia.
    Kim SH; Wang R; Gordon DJ; Bass J; Steiner DF; Lynn DG; Thinakaran G; Meredith SC; Sisodia SS
    Nat Neurosci; 1999 Nov; 2(11):984-8. PubMed ID: 10526337
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proteolytic processing of familial British dementia-associated BRI variants: evidence for enhanced intracellular accumulation of amyloidogenic peptides.
    Kim SH; Creemers JW; Chu S; Thinakaran G; Sisodia SS
    J Biol Chem; 2002 Jan; 277(3):1872-7. PubMed ID: 11709554
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Humoral immune response to fibrillar beta-amyloid peptide.
    Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
    Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease.
    Webster S; Lue LF; Brachova L; Tenner AJ; McGeer PL; Terai K; Walker DG; Bradt B; Cooper NR; Rogers J
    Neurobiol Aging; 1997; 18(4):415-21. PubMed ID: 9330973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.